Cover Image

Raltegravir in the management of HIV-infected patients

Hans-Jürgen StellbrinkICH and IPM Study Center Hamburg, Hamburg, GermanyAbstract: Raltegravir has recently been licensed for the treatment of HIV-1 infection. Currently its use is limited to treatment-experienced patients and subjects with resistant virus. In addition to its activity in the...

Full description

Saved in:

Bibliographic Details
Main Author:	Hans-Jürgen Stellbrink (Author)
Format:	Book
Published:	Dove Medical Press, 2008-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical utility of raltegravir for the treatment of HIV infection in children and adolescents
by: Nuttall J, et al.
Published: (2013)

Raltegravir for HIV-1 infected children and adolescents: efficacy, safety, and pharmacokinetics
by: Larson KB, et al.
Published: (2013)

Raltegravir: first in class HIV integrase inhibitor
by: Zelalem Temesgen, et al.
Published: (2008)

Antiretroviral therapy containing raltegravir to prevent mother-to-child transmission of HIV in infected pregnant women
by: Diego M. Cecchini, et al.
Published: (2017)

ASSESSMENT OF ECONOMIC EFFICIENCY OF APPLICATION OF RALTEGRAVIR BY PATIENTS WITHOUT EXPERIENCE OF TYPE 1 HIV INFECTION THERAPY IN RUSSIA
by: Elamin H. Elbasha, et al.
Published: (2015)

Pharmacoeconomic analysis of the etravirine compared to raltegravir in treatment HIV-infected adult patients, previously treated with antiretroviral drugs
by: Y. I. Ashikhmin, et al.
Published: (2018)

Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification
by: Jintanat Ananworanich, et al.
Published: (2015)

HIV-1 resistance patterns to integrase inhibitors in Chilean patients with virological failure on raltegravir-containing regimens
by: Pablo Ferrer, et al.
Published: (2020)

Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission
by: Thanyawee Puthanakit, et al.
Published: (2018)

Raltegravir Attenuates Experimental Pulmonary Fibrosis In Vitro and In Vivo
by: Xue Zhang, et al.
Published: (2019)

Dissolution Enhancement of Raltegravir by Hot Melt Extrusion Technique
by: Ahmed S. Abdul Jabbar
Published: (2018)

Urinary Eicosanoid Metabolites in HIV-Infected Women with Central Obesity Switching to Raltegravir: An Analysis from the Women, Integrase, and Fat Accumulation Trial
by: Todd Hulgan, et al.
Published: (2014)

Inhibidores de la integrasa y raltegravir en el manejo de la infección por virus de la inmunodeficiencia humana en la era de la resistencia a múltiples medicamentos Integrase Inhibitors and raltegravir use in the management of HIV infection in the era of multidrug resistance
by: Fredy Guevara, et al.
Published: (2010)

Clinical resistance to dolutegravir assessed by next generation sequencing in pre-exposed raltegravir patients
by: Philippe Halfon, et al.
Published: (2018)

A population pharmacokinetics analysis assessing the exposure of raltegravir once‐daily 1200 mg in pregnant women living with HIV
by: Vera E. Bukkems, et al.
Published: (2021)

Novel Perspectives on the Design and Development of a Long-Acting Subcutaneous Raltegravir Injection for Treatment of HIV-In Vitro and In Vivo Evaluation
by: Heba S. Abd-Ellah, et al.
Published: (2023)

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing
by: Jos Lommerse, et al.
Published: (2019)

Fármacos recentes usados para o tratamento da infecção pelo HIV-1: enfuvirtida, maraviroc, raltegravir e etravirina
by: M.A. Brito
Published: (2011)

Physiologically Based Pharmacokinetic Modelling of UGT Substrate Drugs Lamotrigine and Raltegravir during Pregnancy
by: Monika Berezowska, et al.
Published: (2024)

Efficacy and Safety of Raltegravir-Based Dual Therapy in AIDS Patients: A Meta-Analysis of Randomized Controlled Trials
by: Yinqiu Huang, et al.
Published: (2019)

Selective and rapid determination of raltegravir in human plasma by liquid chromatographyâtandem mass spectrometry in the negative ionization mode
by: Ajay Gupta, et al.
Published: (2015)

Optimising neonatal antiretroviral therapy using raltegravir: a qualitative analysis of healthcare workers' and caregivers' perspectives
by: Angela Mushavi, et al.
Published: (2022)

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients
by: Restelli U, et al.
Published: (2017)

Immunology of fibrotic lung disease: managing infections whilst preventing autoimmunity?
by: Thomas Hügle
Published: (2011)

Management of genital herpes infections in HIV infected patients
by: Samraj S, et al.
Published: (2006)

Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach
by: Purushothaman Indu, et al.
Published: (2020)

Advances in management of HIV infection
by: Mukherjee Sukumar
Published: (2005)

Efficacy of Sovodak in the Management of Patients Co-infected with HIV/HCV
by: Mohammad Hossein Somi, et al.
Published: (2020)

Pityrosporum Infection In HIV Infected Patients
by: Kaviarasan P K, et al.
Published: (2001)

THE MODERN VIEW OF THE MANAGEMENT OF PREGNANCY IN HIV INFECTION
by: I. O. Makarov, et al.
Published: (2016)

Management of HIV-hepatitis B co-infection
by: Marc Mendelson
Published: (2011)

Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection
by: Christine Katlama, et al.
Published: (2009)

30-days mortality in patients with perforated peptic ulcer: A national audit
by: Anne Nakano, et al.
Published: (2008)

Guidelines for the prevention, diagnosis and management of cryptococcal meningitis and disseminated cryptococcosis in HIV-infected patients
by: Kerrigan McCarthy, et al.
Published: (2007)

Neurosyphilis in HIV-infected patients
by: T. V. Krasnoselskikh, et al.
Published: (2017)

Managing the HIV-infected neonate: A rural doctor's perspective
by: D. Demas, et al.
Published: (2014)

OROPHARYNGEAL MANIFESTATIONS IN HIV INFECTED PATIENTS
by: Gabriela Juganariu, et al.
Published: (2011)

Oral diseases in patients infected with HIV
by: Dominika Magdalena Egierska, et al.
Published: (2022)

FEATURES OF PNEUMONIA IN HIV-INFECTED PATIENTS
by: M. T. Vatutin, et al.
Published: (2016)

Epidemiology of Opportunistic Infections in HIV Infected Patients on Treatment in Accredited HIV Treatment Centers in Cameroon
by: Ornella Sybile D. Kouanfack, MD, et al.
Published: (2019)